C-reactive protein level in severe stenosis of cerebral arteries

Cerebrovascular Diseases

Volumn 23, Issue 5-6, 2007, Pages 430-434

  Flegar Meštrić, Zlata ^a   Vrhovski Hebrang, Danijela ^a   Preden Kereković, Vlatka ^a   Perkov, Sonja ^a   Hebrang, Andrija ^a   Grga, Ante ^a   Januš, Dragutin ^a   Vidjak, V ^a  

^a University of Zagreb   (Croatia)

Author keywords

C reactive protein; Cerebral arteries; Digital subtraction angiography; Stenosis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SALVAGE; BRAIN ANGIOGRAPHY; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY, DIGITAL SUBTRACTION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CEREBRAL ARTERIES; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; IMMUNOASSAY; INTRACRANIAL ARTERIOSCLEROSIS; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 34248336547     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101467     Document Type: Article

References (27)

1. Paffen E, Demaat MP: C-reactive protein in atherosclerosis: a causal factor? Cardiovasc Res 2006;71:30-39.
2. Alvarez Garcia B, Ruiz C, Chacon P, Sabin JA, Matas M: High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. J Vasc Surg 2003;38:1018-1024.
3. Whicher J, Biasucci L, Rifai N: Inflammation, the acute phase response and atherosclerosis. Clin Chem Lab Med 1999;37:495-503.
4. Libby P, Ridker PM: Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 2004;116:9S-16S.
5. Verma S, Szmitko PE, Ridker PM: C-reactive protein comes of age. Nat Clin Pract Cardiovasc Med 2005;2:29-36.
6. Chamorro A: Role of inflammation in stroke and atherothrombosis. Cerebrovasc Dis 2004;17(suppl 3):1-5.
7. Masotti L, Ceccarelli E, Forconi S, Cappelli R: Prognostic role of C-reactive protein in very old patients with acute ischaemic stroke. J Intern Med 2005;258:145-152.
8. 2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med 2005;165:2479-2484.
9. Rifai N, Ridker PM: Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem 2001;47:28-30.
10. Rifai N, Ridker PM: High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 2001;47:403-411.
11. Vainas T, Stassen FR, de Graaf R, Twiss EL, Herngreen SB, Welten RJ, van den Akker LH, van Dieijen-Visser MP, Bruggeman CA, Kitslaar PJ: C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events. J Vasc Surg 2005;42:243-251.
12. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-428.
13. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG: C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 2005;112:976-983.
14. Hamwi A, Vukovich T, Wagner O, Rumpold H, Spies R, Stich M, Langecher C: Evaluation of turbidimetric high-sensitivity C-reactive protein assay for cardiovascular risk estimation. Clin Chem 2001;47:2044-2046.
15. Koenig W: Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein. Int J Cardiol 2005;98:199-206.
16. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453.
17. WHO Expert Committee: WHO physical status: the use of interpretation of anthropometry. Tech Rep Ser No 854. Geneva, WHO, 1995, pp 368-369.
18. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomér K, Perk J, PyöräläK, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D: European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis 2004;173:381-391.
19. Reiner Z, Tedeschi-Reiner E: Atherosclerosis - A paradox of eastern European countries. Atherosclerosis 2006;suppl 7:461.
20. Turek S, Rudan I, Smolej-Narančić N, Szirovica L, Ćubrilo-Turek M, Žerjavić-Hrabak V, Rak-Kaić A, Vrhovski-Hebrang D, Prebeg Z, Ljubičić M, Janič ijević B, Rudan P: A large cross-sectional study of health attitudes, knowledge, behavior and risks in the post-war Croatian population (the First Croatian Health Project). Coll Antropol 2001;25:77-96.
21. Lobbes MBI, Lutgens E, Heeneman S, Cleutjens KBJM, Kooi ME, van Engelshoven JMA, Daemen MJAP, Nelemans PJ: Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease. Atherosclerosis 2006;187:18-25.
22. Després JP, Lemieux I, Dagenais GR, Cantin B, Lamarche B: Evaluation and management of atherogenic dyslipidemia: beyond low-density lipoprotein cholesterol. CMAJ 2001;165:1331-1333.
23. Podobnik-Šarkanji S, Demarin V, Rundek T: Impact of risk factors on the morphology of carotid artery plaques and stroke. Acta Clin Croat 1997;36:77-83.
24. Parrinello G, Barbagallo CM, Pinto A, Amato P, Cecala MG, Noto D, Cefalu AB, Scalisi G, Notarbartolo A, Averna MR, Licata G: Carotid atherosclerosis in hypercholesterolemic patients: relationship with cardiovascular events. Nutr Metab Cardiovasc Dis 2001;11:96-103.
25. Di Napoli M, Papa F: C-reactive protein and cerebral small-vessel disease: an opportunity to reassess small-vessel disease physiopathology? Circulation 2005;112:781-785.
26. Hollander M, Hak AE, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Witteman JCM, Breteler MMB: Comparison between measures of atherosclerosis and risk of stroke. The Rotterdam Study. Stroke 2003;34:2367.
27. Rerkasem K, Sherman CP, Williams A, Morris GE, Philips MJ, Calder PC, Grimble RF: C-reactive protein is elevated in symptomatic compared with asymptomatic patients with carotid artery disease. Eur J Vasc Surg 2002;23:505-509.